Latanoprost; Netarsudil Dimesylate Patent Expiration

Latanoprost; Netarsudil Dimesylate is Used for lowering high eye pressure. It was first introduced by Alcon Laboratories Inc in its drug Rocklatan on Mar 12, 2019.


Latanoprost; Netarsudil Dimesylate Patents

Given below is the list of patents protecting Latanoprost; Netarsudil Dimesylate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Rocklatan US10174017 Dual mechanism inhibitors for the treatment of disease Jan 27, 2030 Alcon Labs Inc
Rocklatan US10532993 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds Jul 11, 2026 Alcon Labs Inc
Rocklatan US10588901 Combination therapy Mar 14, 2034 Alcon Labs Inc
Rocklatan US10654844 Dual mechanism inhibitors for the treatment of disease Jan 27, 2030 Alcon Labs Inc
Rocklatan US10882840 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds Jul 11, 2026 Alcon Labs Inc
Rocklatan US11021456 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds Jul 11, 2026 Alcon Labs Inc
Rocklatan US11028081 Dual mechanism inhibitors for the treatment of disease Jan 27, 2030 Alcon Labs Inc
Rocklatan US11185538 Compositions for treating glaucoma or reducing intraocular pressure Mar 14, 2034 Alcon Labs Inc
Rocklatan US11197853 Combination therapy Mar 14, 2034 Alcon Labs Inc
Rocklatan US11618748 Dual mechanism inhibitors for the treatment of disease Jan 27, 2030 Alcon Labs Inc
Rocklatan US8394826 Dual mechanism inhibitors for the treatment of disease Nov 10, 2030 Alcon Labs Inc
Rocklatan US8450344 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds Jul 11, 2026 Alcon Labs Inc
Rocklatan US9096569 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds Jul 11, 2026 Alcon Labs Inc
Rocklatan US9415043 Combination therapy Mar 14, 2034 Alcon Labs Inc
Rocklatan US9931336 Combination therapy Mar 14, 2034 Alcon Labs Inc
Rocklatan US9993470 Combination therapy Mar 14, 2034 Alcon Labs Inc


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳